These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28960567)

  • 1. Hepatitis C in a new therapeutic era: Recontextualising the lived experience.
    Whiteley D; Whittaker A; Elliott L; Cunningham-Burley S
    J Clin Nurs; 2018 Jul; 27(13-14):2729-2739. PubMed ID: 28960567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lived experience of interferon-free treatments for hepatitis C: A thematic analysis.
    Whiteley D; Whittaker A; Elliott L; Cunningham-Burley S
    Int J Drug Policy; 2016 Dec; 38():21-28. PubMed ID: 27842250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with hepatitis C: a phenomenological study.
    Hill R; Pfeil M; Moore J; Richardson B
    J Clin Nurs; 2015 Feb; 24(3-4):428-38. PubMed ID: 24811299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.
    Treloar C; Rhodes T
    Qual Health Res; 2009 Sep; 19(9):1321-34. PubMed ID: 19690211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of interferon-based treatments for hepatitis C infection.
    Hopwood M; Treloar C
    Qual Health Res; 2005 May; 15(5):635-46. PubMed ID: 15802540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'.
    Harris M
    Int J Drug Policy; 2017 Sep; 47():161-168. PubMed ID: 28455145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living with hepatitis C and treatment: the personal experiences of patients.
    Sgorbini M; O'Brien L; Jackson D
    J Clin Nurs; 2009 Aug; 18(16):2282-91. PubMed ID: 19583661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience.
    Goutzamanis S; Doyle J; Higgs P; Hellard M
    J Viral Hepat; 2019 Feb; 26(2):218-223. PubMed ID: 30315689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.
    Akiyama MJ; Ross J; Rimawi F; Fox A; Jordan AO; Wiersema J; Litwin AH; Kaba F; MacDonald R
    PLoS One; 2020; 15(12):e0242623. PubMed ID: 33264311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?
    de Mendoza C
    AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lived experience of treatment for hepatitis C.
    Kinder M
    Gastroenterol Nurs; 2009; 32(6):401-8. PubMed ID: 20010233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic update in hepatitis C].
    Devesa MJ; Cuenca F; Izquierdo S; Sánchez-Pobre P; Ladero JM; López-Alonso G; Díaz-Rubio M; Rey E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():48-51. PubMed ID: 26365735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era.
    Chasser Y; Kim AY; Freudenreich O
    Psychosomatics; 2017; 58(1):1-10. PubMed ID: 27871760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness trajectory of initial infection for patients with hepatitis C: A qualitative study.
    Tsai SM; Kao JT; Tsai YF
    Nurs Health Sci; 2019 Mar; 21(1):112-118. PubMed ID: 30251452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lived Experience of Patients Utilizing Second-Generation Direct-Acting Antiviral for Treatment of Chronic Hepatitis C Virus Infection: A Phenomenological Analysis.
    Nascimento YA; Silva LD; Ramalho de Oliveira D
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.
    Golfieri L; Gitto S; Morelli MC; Pinna AD; Grandi S; Andreone P
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):759-765. PubMed ID: 28756716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus vaccines in the era of new direct-acting antivirals.
    Shi C; Ploss A
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):171-85. PubMed ID: 23363265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.